IQVIA has come up with the key trends that emerging biotech and emerging biopharma companies should look out for in 2022...
MicroPort CRM, a pioneering company in the field of Cardiac Rhythm Management, headquartered in France, has recentl...
Takeda Pharmaceutical Company has announced the exercise of its option to acquire Adaptate Biotherapeutics, a UK-based c...
An international research group at the RIKEN Cluster for Pioneering Research (CPR) in Japan has successfully treated can...
The McQuade Center for Strategic Research and Development, LLC (MSRD), established in the US by Japan-based Otsuka Pharm...
Japan-based Shimadzu Corporation has invested in Bacchus Bio innovation, a startup company spun off from Kobe University...
PRISM BioLab, a Japan based biotechnology company with a proprietary peptide mimetic small molecule drug discovery ...
Via drug repositioning, a team of scientists at the Osaka City University in Japan has created a combination of rifampic...
An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants. Th...
Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics have announced that Japan’...
Japanese firm Eisai has entered into an agreement with Gilead Sciences, Inc. for the commercialisation and distribution ...
US-based Brand Institute has announced its successful partnership with Moderna in naming their mRNA COVID-19 vaccine: SP...
US-based BostonGene Corporation and Japanese firm NEC Corporation have announced a strategic global partnershi...
Jolly Good Inc. in collaboration with Aichi Medical University Hospital's Pain Center, the first interdisciplinary treat...
Shimadzu Corporation has released six new models in its AP-AD series of analytical balances simultaneously in Japan and ...
Eurofins Scientific has announced a share purchase agreement with Japan-based Transgenic Inc. to acquire Genetic Lab (G ...
In a recent study, researchers from Kanazawa University in Japan have visualized structural changes on the surface of SA...
Japan-based Shionogi & Co. has recently announced the results from the Japanese Phase 1/2 clinical trial of S-268019...
